title: [Metabolic changes in blood oxygen in the human heart under ischemic and reperfusion conditions].
abstract: The number of granulocytes, their capability to generate O2-. and the activity of SOD-1, GSH-Px, Cat as well as MDA concentrations in erythrocytes in the blood extracted from the venous sinus and aorta under coronary artery bypass with use of St. Thomas cardioplegic solution were determined. The blood for examination was obtained before the institution of cardiopulmonary bypass, in the period of the deepest ischaemia (just after declamping of the aorta) and between the 1-3 minute and the 10-13 minute of reperfusion. A rise in the number of granulocytes both in the venous sinus and aortal blood at all examined intervals was noted. Capability to produce superoxide anion radicals decreased at the peak of ischemia and during reperfusion. The activity of SOD-1 was lower both after the period of ischemia and reperfusion. A rise in aortal blood activity during reperfusion was characteristic for GSH-Px; the activity was greater in the blood sampled from the coronary sinus during ischemia and initial reperfusion. With the exception of the initial reperfusion the activity of Cat diminished in all observed cases. We did not observe any significant changes in MDA concentration with the exception of the initial reperfusion in the aortal blood and later during reperfusion in the blood from the coronary sinus. The results demonstrate that the applied cardioplegic solution may protect myocardium from harmful effects of active oxygen froms produced as a results of ischemia and reperfusion.
authors.affiliation: I Kliniki Chorób Wewnetrznych IMW WAM w Lodzi.
authors.forename: L
authors.initials: L
authors.lastname: Pawlicki
authors.forename: J
authors.initials: J
authors.lastname: Zasłonka
authors.forename: J
authors.initials: J
authors.lastname: Kedziora
authors.forename: J
authors.initials: J
authors.lastname: Błaszczyk
authors.forename: E
authors.initials: E
authors.lastname: Sibińska
authors.forename: M
authors.initials: M
authors.lastname: Mussur
authors.forename: R
authors.initials: R
authors.lastname: Jaszewski
authors.forename: A
authors.initials: A
authors.lastname: Iwaszkiewicz
authors.forename: R
authors.initials: R
authors.lastname: Golański
authors.forename: E
authors.initials: E
authors.lastname: Szymańska
authors.forename: B
authors.initials: B
authors.lastname: Stefaniak
mesh_terms: D000328:Adult; D000368:Aged; D002314:Cardioplegic Solutions / Q000494:pharmacology; D002315:Cardiopulmonary Bypass; D005260:Female; D006098:Granulocytes / Q000166:cytology; D006321:Heart / Q000187:drug effects; D006801:Humans; D007958:Leukocyte Count; D008297:Male; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000097:blood*; D015425:Myocardial Reperfusion; D010100:Oxygen / Q000097:blood*; D017382:Reactive Oxygen Species / Q000378:metabolism
chemical_list: D002314:Cardioplegic Solutions; D017382:Reactive Oxygen Species; D010100:Oxygen